# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-134200
Filing Date
2024-05-08
Accepted
2024-05-08 16:06:57
Documents
98
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d776015d10q.htm iXBRL | 10-Q | 2024877
2 | EX-10.1 | d776015dex101.htm | EX-10.1 | 73671
3 | EX-31.1 | d776015dex311.htm | EX-31.1 | 10353
4 | EX-31.2 | d776015dex312.htm | EX-31.2 | 10343
5 | EX-32 | d776015dex32.htm | EX-32 | 4331
| Complete submission text file | 0001193125-24-134200.txt |  | 11658682

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20240331.xsd | EX-101.SCH | 93429
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20240331_cal.xml | EX-101.CAL | 50494
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20240331_def.xml | EX-101.DEF | 610169
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20240331_lab.xml | EX-101.LAB | 629165
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20240331_pre.xml | EX-101.PRE | 640145
102 | EXTRACTED XBRL INSTANCE DOCUMENT | d776015d10q_htm.xml | XML | 2280821

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 24925972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)